Your browser doesn't support javascript.
loading
Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.
Brink, Mirian; Minnema, Monique C; Visser, Otto; Levin, Mark-David; Posthuma, Eduardus F M Ward; Broijl, Annemiek; Sonneveld, Pieter; van der Klift, Marjolein; Roeloffzen, Wilfried W H; Westerman, Matthijs; van Rooijen, Cleo R; Geerts, Paul A F; Zweegman, Sonja; van de Donk, Niels W C J; Dinmohamed, Avinash G.
Afiliación
  • Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. m.brink@iknl.nl.
  • Minnema MC; Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands.
  • Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Posthuma EFMW; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.
  • Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • Roeloffzen WWH; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands.
  • van Rooijen CR; Department of Hematology, Medical Center Twente, Enschede, The Netherlands.
  • Geerts PAF; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.
  • Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Blood Cancer J ; 12(3): 41, 2022 03 15.
Article en En | MEDLINE | ID: mdl-35292622
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Mieloma Múltiple Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos